Summary
Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can cross-react with mammalian proteins. Focusing on neurological symptoms, Kreye et al. discuss whether these cross-reactive antibodies could contribute to COVID-19 disease pathology and to the persistence of symptoms in patients who have cleared the initial viral infection.
Do cross-reactive antibodies cause neuropathology in COVID-19? (6 October 2020)
https://www.nature.com/articles/s41577-020-00458-y?fbclid=IwAR17RU5-zCo4k3Cc_JAtxsk_2uX4hTMtrJZyvrBR7ulj4PFSMzOxxFaEkO4
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now